Labshake search
Citations for BioLegend :
51 - 100 of 8257 citations for Recombinant Human Lectin Galactoside Binding Soluble 1 since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cell Biology 2024Quote: ... and 1 µg / ml soluble anti-CD28 (BioLegend, Cat. # 1002116). Cells were stained for live/dead cells ...
-
bioRxiv - Cancer Biology 2023Quote: ... supplemented with 5 % human AB serum (Gemini Bio) and 30 U / mL recombinant human IL-2 (BioLegend) [9] ...
-
bioRxiv - Cancer Biology 2023Quote: ... supplemented with 5 % human AB serum (Gemini Bio) and 30 U / mL recombinant human IL-2 (BioLegend). The viability of NALM6-GL cells was then assessed by adding 150 ug / mL D-Luciferin (PerkinElmer ...
-
bioRxiv - Pharmacology and Toxicology 2020Quote: ... a final concentration of 5ng/ml of recombinant human TGFβ1 (BioLegend, #580702) was added to the culture media and treated for 24~48 hours ...
-
bioRxiv - Immunology 2022Quote: ... 100ng/ml of recombinant human (rh) IL-8 (Biolegend, San Diego, CA) were added to the apical side of the enteroid monolayers (76) ...
-
bioRxiv - Microbiology 2022Quote: ... in the presence of 50 ng/mL recombinant human M-CSF (Biolegend) for 7 days ...
-
bioRxiv - Cancer Biology 2020Quote: ... in DMEM/F12 supplemented with human recombinant EGF (20 ng/mL, BioLegend), bFGF (20 ng/mL ...
-
bioRxiv - Cancer Biology 2023Quote: ... CAR-NK cells were loaded with human recombinant PD-L1- Fc (Biolegend) or ErBb2-Fc fusion proteins (R&D Systems ...
-
bioRxiv - Immunology 2023Quote: ... and 200 ng/mL recombinant human B cell-activating factor (BAFF, BioLegend).
-
bioRxiv - Cancer Biology 2022Quote: ... 10 ng/mL human recombinant IL-3 (BioLegend, San Diego, CA, USA) and antibiotics ...
-
bioRxiv - Microbiology 2023Quote: ... in the presence of 50 ng/mL recombinant human M-CSF (Biolegend) for 7 days ...
-
bioRxiv - Cancer Biology 2024Quote: ... Recombinant human NRG1 was acquired from BioLegend (San Diego, CA, Cat. 551904). High-throughput drug screening assays were used with compounds sourced as indicated in Suppl ...
-
bioRxiv - Immunology 2021Quote: ... non-specific binding was blocked using Fc Receptor blocking solution (Human TruStain FcX, BioLegend) and cells were stained with antibodies in PBS supplemented with 2% hiFCS for 30 minutes at 4°C ...
-
bioRxiv - Developmental Biology 2023Quote: ... Non-specific bindings were blocked using Human TruStain FcX (Fc Receptor Blocking Solution, BioLegend) for 10 min on ice in the dark ...
-
bioRxiv - Cancer Biology 2024Quote: ... and nonspecific binding was blocked with either Human TruStain FcX™ (422301, Biolegend, USA) or anti-mouse CD16/CD32 blocking antibody (101319 ...
-
bioRxiv - Cancer Biology 2024Quote: ... Non-specific antibody binding was precluded with Human TruStain FcX™ (422301, Biolegend, USA). A suite of fluorochrome-conjugated monoclonal antibodies was then employed to identify surface antigens ...
-
bioRxiv - Microbiology 2020Quote: ... Cells were activated with soluble anti-CD3 (clone UCHT-1) (Biolegend) for 5 days prior to infection or analysis as previously described (27).
-
bioRxiv - Immunology 2022Quote: ... soluble 1 μg/mL anti-mouse CD28 mAb (clone 37.51, BioLegend), and 1 ng/mL mouse IL-2 (BD Biosciences ...
-
bioRxiv - Immunology 2021Quote: ... with 1 ug/ml soluble anti-CD28 antibody (BioLegend, LEAF grade) and 5 ng/ml IL-2 (carrier-free ...
-
bioRxiv - Immunology 2022Quote: ... neutrophils were incubated with autologous activated platelets (1:10 ratio) (65) for 2.5h and human recombinant CCL28 (50 nM) (BioLegend), the CCR3 antagonist SB328437 (10 mM ...
-
bioRxiv - Cancer Biology 2022Quote: ... or TFH mimicking signals (including 0.02 μg/mL recombinant human IL-4, Peprotech; 0.05 μg/ml recombinant human IL-21, Peprotech, and 5 μg/mL anti-human CD40, Biolegend). Complete RPMI medium contained RPMI 1640 (Gibco ...
-
bioRxiv - Immunology 2023Quote: ... Human Th17 differentiation assays were performed similarly except the concentrations of recombinant human IL-6 (30 ng/ml, BioLegend), TGF- β1 (2.25ng/mL) ...
-
bioRxiv - Immunology 2020Quote: ... and soluble CD28 (Biolegend #302943) antibodies with the presence of 20 ng/μl IL-2 (Biolegend #589106 ...
-
bioRxiv - Immunology 2020Quote: ... and were cultured with 50 ng/ml recombinant human GM-CSF (BioLegend #572904) and 50 ng/ml recombinant human M-CSF (BioLegend #574806 ...
-
bioRxiv - Bioengineering 2021Quote: ... and 20 ng/mL recombinant human IL-3 (BioLegend; San Diego, CA, USA) to determine cellular distribution ...
-
bioRxiv - Cancer Biology 2021Quote: ... Cells were then treated with 100 ng/ml of recombinant human IFNγ (Biolegend) for 24h ...
-
bioRxiv - Cancer Biology 2022Quote: ... “Rescue” wells were treated with 0.8 ug/mL recombinant human periostin (BioLegend 770506). Scratches were imaged at 0 hours ...
-
bioRxiv - Immunology 2022Quote: ... Recombinant human SARS-CoV-2 spike S1 IgG lyophilized antibody (Clone AM009105, BioLegend) was used as a standard.
-
bioRxiv - Immunology 2023Quote: ... Biotinylated lectins were detected using PE-Streptavidin (Biolegend).
-
bioRxiv - Immunology 2022Quote: ... 5×104 B cells were first incubated with 5 µg/ml anti-IgM complexes and 1 µg/ml recombinant Human CD40L (Biolegend) for 30 mins and then 1×104 Tfr cells were added ...
-
bioRxiv - Immunology 2023Quote: ... 200 μl for 96-well plates) supplemented with 1 μg/ml of recombinant human B cell-activating factor (BAFF, BioLegend). 1 µg/ml rHA from H1N1 (PR8 ...
-
bioRxiv - Immunology 2022Quote: ... and soluble 1 μg/mL anti-mouse CD28 mAb (clone 37.51, BioLegend) under Th1-polarizing conditions [1 ng/mL mouse IL-2 (BD Bioscience ...
-
bioRxiv - Cancer Biology 2022Quote: ... The “rescue” wells were treated with 0.8 ug/mL recombinant human periostin (BioLegend 770506). After 24 hours ...
-
bioRxiv - Developmental Biology 2022Quote: ... Plates were coated with recombinant human E-cadherin-Fc chimera (BioLegend #BLG-779904-25ug) to reduce colony formation and thereby limit the potential impact of paracrine and direct cell signaling in regulating gene expression of related cells 50 ...
-
bioRxiv - Immunology 2023Quote: ... and 2 ng/ml human interleukin (IL)-2 recombinant (BioLegend, San Diego, CA, 589104).
-
bioRxiv - Cancer Biology 2024Quote: ... cells were treated with different combinations of 400 ng/mL human recombinant sFasL (Biolegend), 40 μM Fasudil HCl (SellekChem) ...
-
bioRxiv - Immunology 2023Quote: ... For the memory B cell EliSpot, PBMC were stimulated with 1 µg/ml R848 (SigmaAldrich, SML0196) and 10 ng/ml recombinant human IL-2 (Biolegend, 791904) for 5 days before harvesting and plating of 50-100.000 cells/well ...
-
Mapping of the autophagosomal degradome identifies IL-7Rα as key cargo in proliferating CD4+ T-cellsbioRxiv - Immunology 2021Quote: ... 1:50 diluted in Annexin V binding buffer (BioLegend). Apoptotic cells were gated on the LIVE/DEAD-negative ...
-
bioRxiv - Immunology 2022Quote: ... 1 µg recombinant mouse IL-23 (Biolegend) was intradermally injected per ear ...
-
bioRxiv - Immunology 2022Quote: ... and soluble anti-CD28 (Biolegend, #102116) antibodies in Th17 or Treg skewing conditions ...
-
bioRxiv - Immunology 2020Quote: ... soluble anti-mouse CD28 (102112, Biolegend) was added to cells at 2 µg/mL ...
-
bioRxiv - Immunology 2023Quote: ... soluble anti-CD28 (1µg/mL; Biolegend), plate-bound anti-CD3 antibody (5μg/mL ...
-
bioRxiv - Immunology 2023Quote: ... soluble anti-CD28 (1µg/mL; Biolegend) and plate-bound anti-CD3 antibody (5 μg/mL ...
-
bioRxiv - Cancer Biology 2021Quote: ... Lectin solution was removed and HRP-conjugated streptavidin (Biolegend) was added and incubated at RT for 90 min followed by two additional washes with PBST ...
-
bioRxiv - Cancer Biology 2021Quote: ... Lectin solution was removed and HRP-conjugated streptavidin (Biolegend) was added and incubated at RT for 90 mins followed by two additional washes with PBST ...
-
bioRxiv - Neuroscience 2020Quote: ... neuronal cultures were treated with 200 ng/mL recombinant human NRG1 (BioLegend, Cat. No. 551904) for 48 hrs ...
-
bioRxiv - Immunology 2024Quote: ... The ultrasound-guided intra-amniotic injection of recombinant human HMGB1 (Biolegend, San Diego, CA, USA) at a concentration of 9 ng dissolved in 100 μL of sterile 1X phosphate-buffered saline (PBS ...
-
bioRxiv - Cancer Biology 2023Quote: ... Primary antibodies binding markers: CD81 (cat# 104902, Biolegend 1:1000), and ALIX (cat# 634502 ...
-
bioRxiv - Immunology 2019Quote: ... recombinant murine ICAM-1 (R&D Systems, BioLegend), 4-Hydroxytamoxifen (Tocris) ...
-
bioRxiv - Cancer Biology 2020Quote: ... 2.0 μg/ml soluble CD28 (37.51; Biolegend), 20 ng/ml IL-2 (BD Pharmingen) ...